SCHEMBL8803937

SCHEMBL8803937

Cc1nc2ncccn2c(=O)c1CCN1CC2CC(c3ccc(F)cc3)C2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.42
▸ CYP2D6 P10635 4/20 0.42
▸ TSHR P16473 4/20 0.42
▸ HTR2C P28335 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ PMP22 Q01453 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ PKM P14618 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ THPO P40225 1/20 0.42
▸ ACHE P22303 2/20 0.42
▸ ADRA1A P35348 8/20 0.38
▸ ADRA2A P08913 7/20 0.38
▸ ADRA2B P18089 7/20 0.38
▸ ADRA2C P18825 7/20 0.38
▸ HTR2A P28223 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8805236 0.86 ACHE (0.58) HTR1ACYP2D6TSHRHTR2CMAPT
Hydrochloric Acid SCHEMBL8804162 0.85 ACHE (0.57) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8805327 0.85 ADRA2A (0.46) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8804086 0.84 CYP2D6 (0.36) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8802345 0.81 HTR2A (0.47) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8803857 0.81 CYP2D6 (0.39) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8802868 0.81 PKM (0.58) HTR1ACYP2D6TSHRHTR2CMAPT
Hydrochloric Acid SCHEMBL8807357 0.81 PKM (0.57) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8803166 0.80 ADRA1A (0.45) HTR1ACYP2D6TSHRHTR2CMAPT
SCHEMBL8806120 0.80 CYP2D6 (0.36) HTR1ACYP2D6TSHRHTR2CMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647231-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS, ETC. BASF AG (DE) 1997-08-27 — — EP disclosed
US-5475105-A N-substituted azabicycloheptane derivatives BASF AKTIENGESELLSCHAFT (DE) 1995-12-12 — — US disclosed
Send feedback